Article Information
History
- March 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Katharina Diernberger1,2,*,
- Xhyljeta Luta3,4,
- Joanna Bowden5,6,
- Joanne Droney7,
- Elizabeth Lemmon1,
- Giovanni Tramonti1,
- Bethany Shinkins8,
- Ewan Gray1,
- Joachim Marti3 and
- Peter S Hall1,2
- 1Edinburgh Clinical Trials Unit, University of Edinburgh, United Kingdom
- 2Edinburgh Cancer Research Centre, University of Edinburgh, United Kingdom
- 3Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland
- 4Lausanne University Hospital (CHUV), Lausanne, Switzerland
- 5NHS Fife, Scotland, United Kingdom
- 6University of St Andrews, Scotland, United Kingdom
- 7The Royal Marsden NHS Foundation Trust, London, United Kingdom
- 8Academic Unit of Health Economics, University of Leeds, United Kingdom
- ↵*Corresponding Author: Katharina Diernberger, c/o Peter Hall, Institute of Genetics and Cancer, University of Edinburgh, UK, Phone: +44 (0) 131 6518510, Email: Katharina.diernberger{at}ed.ac.uk
Posted March 03, 2022.
Variation in hospital cost trajectories at the end of life by age, multimorbidity and cancer type
